SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NeuroSigma, Inc. Release: Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™